---
document_datetime: 2025-01-27 11:29:12
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/izba-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: izba-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 3.0586629
conversion_datetime: 2025-12-22 11:49:56.461356
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Izba

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency' s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessmenthistory'section.Forthecompleteproductlifecycleprocedures,pleasealsorefertoEPAR-Procedural stepstakenandscientific information after authorisation (archive).

| Applicationnumber     | Scope                                  | Opinion/ Notification 1 issued on   | Commission Decision Issued2 / amended on   | Product Information affected3   | Summary   |
|-----------------------|----------------------------------------|-------------------------------------|--------------------------------------------|---------------------------------|-----------|
| Variation typeIA_IN / | This was an application for a group of | 22/01/2025                          |                                            | Annex II and                    |           |

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application).Opinions areissuedforallotherprocedures.

CDis issued within two months of the opinion forvariations fallingunder the scope of Article 23.1a(a)of Regulation(Eu)No.712/2012,or within oneyear for other procedures. 3 SmPC (Summary of Product Characteristics), Annex II, Labelling,PL (Package Leaflet).

2A Commission decision(CD)is issued for procedures that affect the terms of themarketing authorisation(e.g.summary of product characteristics,annex II,labelling,package leaflet).The

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000245405   | variations. A.5Change in the name and/or address of a manufacturer/importer of the finished product (including batch release or quality control testing sites)-A.5.a The activities for which the manufacturer/importer is responsible include batch release- Accepted A.ADMINISTRATIVECHANGES-A.7 Deletionofmanufacturing sitesfor an active substance, intermediate or finished product, packagingsite，manufacturerresponsiblefor batchrelease，sitewherebatchcontrol takes place, or supplier of a starting material, reagent orexcipient(when mentioned in the dossier)*-Accepted   | PL   |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------|